As shown in Figure 6, the vaccine group, the CTLA-4 siRNA-containing NLE group and the combination group all induced a significant increase in tumor-infiltrating CD8+ T cells compared to the PBS, naked mRNA, empty NLE, and isotype control groups. The gene discussed is CTLA4; the disease is neoplasm.